Concepedia

Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer

C. Poole, Timothy Perren, Sulochana R. Gawande, Mona Ridderheim, James A. Cook, A. Jenkins, D. Roychowdhury

International Journal of Gynecological Cancer · 2006 · 10 citations · 28 references

References

28

Cancer Statistics, 2001

Robert T. Greenlee, M. B. Hill-Harmon, Thomas S. Murray et al. · CA A Cancer Journal for Clinicians · 2001 · 3.3K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer et al. · Journal of Clinical Oncology · 2003 · 2.1K citations

Medicine, Gynecology, Oncology +17

Cancer: Principles and Practice of Oncology

Walter G. Gunn · JAMA · 1997 · 1.3K citations

Medicine, Oncology, Oncology Nursing +10

Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial Neoplasms

William P. McGuire · Annals of Internal Medicine · 1989 · 1.1K citations

Medicine, Oncology, Pharmacology +16

Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.

J.T. Thigpen, John A. Blessing, Harrison Ball et al. · Journal of Clinical Oncology · 1994 · 389 citations

Medicine, Oncology, Pharmacology +17